A detailed history of Empowered Funds, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Empowered Funds, LLC holds 5,847 shares of DXCM stock, worth $471,092. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,847
Previous 5,512 6.08%
Holding current value
$471,092
Previous $624,000 37.34%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$64.0 - $116.06 $21,440 - $38,880
335 Added 6.08%
5,847 $391,000
Q2 2024

Jul 30, 2024

SELL
$110.31 - $140.45 $661 - $842
-6 Reduced 0.11%
5,512 $624,000
Q1 2024

May 06, 2024

BUY
$114.22 - $140.1 $241,575 - $296,311
2,115 Added 62.15%
5,518 $765,000
Q3 2023

Nov 01, 2023

BUY
$86.06 - $137.93 $67,126 - $107,585
780 Added 29.74%
3,403 $317,000
Q2 2023

Jul 27, 2023

BUY
$112.47 - $130.98 $295,008 - $343,560
2,623 New
2,623 $337,000
Q1 2022

Apr 21, 2022

SELL
$94.08 - $130.2 $301,150 - $416,770
-3,201 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$129.87 - $162.82 $415,713 - $521,186
3,201 New
3,201 $1.72 Million
Q4 2020

Feb 02, 2021

SELL
$78.0 - $104.5 $264,186 - $353,941
-3,387 Closed
0 $0
Q3 2020

Oct 26, 2020

SELL
$95.51 - $112.95 $9,073 - $10,730
-95 Reduced 2.73%
3,387 $1.4 Million
Q2 2020

Jul 16, 2020

SELL
$62.68 - $105.34 $48,765 - $81,954
-778 Reduced 18.26%
3,482 $1.41 Million
Q1 2020

Apr 16, 2020

BUY
$47.79 - $75.63 $203,585 - $322,183
4,260 New
4,260 $1.15 Million
Q2 2019

Jul 09, 2019

SELL
$27.84 - $38.92 $289,897 - $405,273
-10,413 Closed
0 $0
Q1 2019

May 10, 2019

BUY
$28.07 - $38.18 $292,292 - $397,568
10,413 New
10,413 $1.24 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Empowered Funds, LLC Portfolio

Follow Empowered Funds, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empowered Funds, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empowered Funds, LLC with notifications on news.